Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
CC-1 / University Hospital Tuebingen
NCT04496674: Bispecific PSMAxCD3 Antibody CC-1 in Patients With Squamous Cell Carcinoma of the Lung	Terminated	1/2	3	Europe	CC-1 and Toczilizumab	German Cancer Research Center, University Hospital Tuebingen	Lung Cancer Squamous Cell	05/23	05/23
DKTK_PMO_1605, NCT04104607: the Bispecific PSMAxCD3 Antibody CC-1 in Patients With Castration Resistant Prostate Carcinoma	Recruiting	1	86	Europe	CC-1, PSMAxCD3	University Hospital Tuebingen, German Cancer Research Center	Castration-Resistant Prostatic Cancer	12/24	12/24
ProSperACC-1, NCT05646550: Antibody CC-1 in Men With Biochemical Recurrence of Prostate Cancer	Recruiting	1	56	Europe	CC-1 Infusion	University Hospital Tuebingen	Prostate Cancer Recurrent	12/25	12/26